SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vista Pharmaceuticals informs about outcome of board meeting

15 Jun 2024 Evaluate
Vista Pharmaceuticals has informed that at the Board of Directors has approved and passed following resolutions by circulation today 12.06.2024: Allotment of 1,06,30,466 equity shares of face value of Rs 2 each issued at price of Rs 10 per equity share including premium of Rs 8 per share to as fully paid-up pursuant to the exercise of 1,06,30,466 convertible warrants at a price of Rs 10 per share (on receipt of excise price of Rs 7.50 per warrant - being 75% of the balance warrant issue price), aggregating to Rs 7,97,28,495 to the non-promoters.

The above information is a part of company’s filings submitted to BSE.

Vista Pharma Share Price

7.72 0.02 (0.26%)
24-Apr-2026 12:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.70
Dr. Reddys Lab 1331.25
Cipla 1289.40
Zydus Lifesciences 930.55
Lupin 2270.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×